(19)
(11) EP 3 113 771 A1

(12)

(43) Date of publication:
11.01.2017 Bulletin 2017/02

(21) Application number: 15758129.9

(22) Date of filing: 02.03.2015
(51) International Patent Classification (IPC): 
A61K 31/404(2006.01)
A61K 31/4738(2006.01)
A61P 25/34(2006.01)
A61K 31/55(2006.01)
A61P 25/30(2006.01)
(86) International application number:
PCT/US2015/018356
(87) International publication number:
WO 2015/134405 (11.09.2015 Gazette 2015/36)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 03.03.2014 US 201461947397 P
13.03.2014 US 201461952724 P
13.03.2014 US 201461952718 P
13.03.2014 US 201461952743 P
13.03.2014 US 201461952736 P
13.03.2014 US 201461952740 P
13.03.2014 US 201461952725 P
12.09.2014 US 201462049968 P

(71) Applicant: DemeRx, Inc.
Fort Lauderdale, Fl 33301 (US)

(72) Inventors:
  • MAILLET, Emeline
    Fort Lauderdale, Florida 33301 (US)
  • FRIEDHOFF, Lawrence
    Fort Lauderdale, Florida 33301 (US)

(74) Representative: Gibson, Mark 
Sagittarius IP Three Globeside Fieldhouse Lane
Marlow, Buckinghamshire SL7 1HZ
Marlow, Buckinghamshire SL7 1HZ (GB)

   


(54) THERAPEUTIC USES OF IBOGAINE AND RELATED COMPOUNDS